Search Ontology:
ChEBI

beta-D-galactosyl-N-(nervonoyl)sphingosine

Term ID
CHEBI:76991
Synonyms
  • (15Z)-N-[(2S,3R,4E)-1-(beta-D-galactopyranosyloxy)-3-hydroxyoctadec-4-en-2-yl]tetracos-15-enamide
  • 1-O-beta-D-galactopyranosyl-N-(nervonoyl)sphingosine
  • 24:1 beta-GalCer
  • beta-GalCer (C24:1)
  • beta-GalCer C24:1
  • C24:1 beta-D-galactosyl ceramide
  • C24:1 beta-GalCer
  • C24:1 GalCer
  • C24:1-beta-glucosyl ceramide
  • D-galactosyl-beta-1,1' N-(15Z-tetracosenoyl)-D-erythro-sphingosine
  • galactosyl(beta) ceramide (d18:1/24:1(15Z))
  • GalCer(d18:1/24:1(15Z))
  • N-(15Z-tetracosenoyl)-1-beta-galactosyl-sphing-4-ene
  • N-(15Z-tetracosenoyl)-1-beta-galactosyl-sphing-4-enine
  • N-nervonoyl-beta-D-galactosylsphingosine
  • N-nervonoyl-beta-galactosylsphingosine
  • N-nervonoylgalactosylsphingosine
  • N-nervonyl-beta-D-galactosylsphingosine
  • N-nervonyl-beta-galactosylsphingosine
  • N-Nervonylgalactosylsphingosine
Definition
A D-galactosyl-N-acylsphingosine where the ceramide N-acyl group is nervonoyl [(15Z)-tetracos-15-enoyl] and the D-galactosyl component has beta anomeric configuration.
References
Ontology
ChEBI  ( EBI )
Resources
CTD
Relationships
is a type of
Phenotype
Phenotype resulting from beta-D-galactosyl-N-(nervonoyl)sphingosine
Phenotype where environments contain beta-D-galactosyl-N-(nervonoyl)sphingosine
Phenotype modified by environments containing beta-D-galactosyl-N-(nervonoyl)sphingosine
Human Disease Model